世界の次世代シーケンシング（NGS）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Next Generation Sequencing (NGS) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4131
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、127ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、次世代シーケンシング（NGS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、プラットフォーム、サービス）、用途別市場規模（学術＆政府研究機関、製薬会社、バイオテクノロジー会社、病院＆クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・次世代シーケンシング（NGS）の市場動向
・企業の競争状況、市場シェア
・次世代シーケンシング（NGS）の種類別市場規模（消耗品、プラットフォーム、サービス）
・次世代シーケンシング（NGS）の用途別市場規模（学術＆政府研究機関、製薬会社、バイオテクノロジー会社、病院＆クリニック）
・次世代シーケンシング（NGS）の北米市場規模2016-2027（アメリカ、カナダ）
・次世代シーケンシング（NGS）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・次世代シーケンシング（NGS）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・次世代シーケンシング（NGS）の中南米市場規模2016-2027（メキシコ、ブラジル）
・次世代シーケンシング（NGS）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Illumina、Thermo Fisher Scientific、Pacific Biosciences of California、Beijing Genomics Institute、Qiagen、Roche、Agilent Technologies、Perkinelmer、Genomatix、PierianDx、Eurofins Scientific、Gatc Biotech、Oxford Nanopore Technologies、Bio-Rad Laboratories、DNASTAR、Biomatters、Partek、New England Biolabs、Myriad Genetics、Macrogen、GATC Biotech）
・結論

NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing.
The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future.

Market Analysis and Insights: Global Next Generation Sequencing (NGS) Market
The global Next Generation Sequencing (NGS) market size is projected to reach US$ 8188.4 million by 2026, from US$ 4745.6 million in 2019, at a CAGR of 8.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Sequencing (NGS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Sequencing (NGS) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Sequencing (NGS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Sequencing (NGS) market.

Global Next Generation Sequencing (NGS) Scope and Market Size
Next Generation Sequencing (NGS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing (NGS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Consumables
Platforms
Services

Segment by Application
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
Beijing Genomics Institute
Qiagen
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Consumables
1.2.3 Platforms
1.2.4 Services
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2016-2027)
2.2 Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Next Generation Sequencing (NGS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Next Generation Sequencing (NGS) Historic Market Share by Regions (2016-2021)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2022-2027)
2.3 Next Generation Sequencing (NGS) Industry Dynamic
2.3.1 Next Generation Sequencing (NGS) Market Trends
2.3.2 Next Generation Sequencing (NGS) Market Drivers
2.3.3 Next Generation Sequencing (NGS) Market Challenges
2.3.4 Next Generation Sequencing (NGS) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Players by Revenue
3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2016-2021)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2016-2021)
3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2020
3.5 Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing (NGS) Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing (NGS) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Sequencing (NGS) Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2016-2021)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2022-2027)

5 Next Generation Sequencing (NGS) Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2016-2021)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2016-2027)
6.2 North America Next Generation Sequencing (NGS) Market Size by Type
6.2.1 North America Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
6.2.2 North America Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
6.2.3 North America Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
6.3 North America Next Generation Sequencing (NGS) Market Size by Application
6.3.1 North America Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
6.3.2 North America Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
6.3.3 North America Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
6.4 North America Next Generation Sequencing (NGS) Market Size by Country
6.4.1 North America Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
6.4.2 North America Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2016-2027)
7.2 Europe Next Generation Sequencing (NGS) Market Size by Type
7.2.1 Europe Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
7.2.2 Europe Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
7.2.3 Europe Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
7.3 Europe Next Generation Sequencing (NGS) Market Size by Application
7.3.1 Europe Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
7.3.2 Europe Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
7.3.3 Europe Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Country
7.4.1 Europe Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
7.4.2 Europe Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size (2016-2027)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type
8.2.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application
8.3.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region
8.4.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Next Generation Sequencing (NGS) Market Size (2016-2027)
9.2 Latin America Next Generation Sequencing (NGS) Market Size by Type
9.2.1 Latin America Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
9.2.2 Latin America Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
9.2.3 Latin America Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
9.3 Latin America Next Generation Sequencing (NGS) Market Size by Application
9.3.1 Latin America Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
9.3.2 Latin America Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
9.3.3 Latin America Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
9.4 Latin America Next Generation Sequencing (NGS) Market Size by Country
9.4.1 Latin America Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
9.4.2 Latin America Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size (2016-2027)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type
10.2.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application
10.3.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country
10.4.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing (NGS) Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences of California
11.3.1 Pacific Biosciences of California Company Details
11.3.2 Pacific Biosciences of California Business Overview
11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
11.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.3.5 Pacific Biosciences of California Recent Development
11.4 Beijing Genomics Institute
11.4.1 Beijing Genomics Institute Company Details
11.4.2 Beijing Genomics Institute Business Overview
11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
11.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.4.5 Beijing Genomics Institute Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
11.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Next Generation Sequencing (NGS) Introduction
11.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
11.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.7.5 Agilent Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
11.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.8.5 Perkinelmer Recent Development
11.9 Genomatix
11.9.1 Genomatix Company Details
11.9.2 Genomatix Business Overview
11.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
11.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.9.5 Genomatix Recent Development
11.10 PierianDx
11.10.1 PierianDx Company Details
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.10.5 PierianDx Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Details
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
11.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.11.5 Eurofins Scientific Recent Development
11.12 Gatc Biotech
11.12.1 Gatc Biotech Company Details
11.12.2 Gatc Biotech Business Overview
11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
11.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.12.5 Gatc Biotech Recent Development
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Details
11.13.2 Oxford Nanopore Technologies Business Overview
11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
11.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.13.5 Oxford Nanopore Technologies Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
11.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 DNASTAR
11.15.1 DNASTAR Company Details
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.15.5 DNASTAR Recent Development
11.16 Biomatters
11.16.1 Biomatters Company Details
11.16.2 Biomatters Business Overview
11.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
11.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.16.5 Biomatters Recent Development
11.17 Partek
11.17.1 Partek Company Details
11.17.2 Partek Business Overview
11.17.3 Partek Next Generation Sequencing (NGS) Introduction
11.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.17.5 Partek Recent Development
11.18 New England Biolabs
11.18.1 New England Biolabs Company Details
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
11.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.18.5 New England Biolabs Recent Development
11.18 Myriad Genetics
.1 Myriad Genetics Company Details
.2 Myriad Genetics Business Overview
.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
.5 Myriad Genetics Recent Development
11.20 Macrogen
11.20.1 Macrogen Company Details
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.20.5 Macrogen Recent Development
11.21 GATC Biotech
11.21.1 GATC Biotech Company Details
11.21.2 GATC Biotech Business Overview
11.21.3 GATC Biotech Next Generation Sequencing (NGS) Introduction
11.21.4 GATC Biotech Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.21.5 GATC Biotech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Consumables
Table 3. Key Players of Platforms
Table 4. Key Players of Services
Table 5. Global Next Generation Sequencing (NGS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Next Generation Sequencing (NGS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Next Generation Sequencing (NGS) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Next Generation Sequencing (NGS) Market Share by Regions (2016-2021)
Table 9. Global Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Next Generation Sequencing (NGS) Market Share by Regions (2022-2027)
Table 11. Next Generation Sequencing (NGS) Market Trends
Table 12. Next Generation Sequencing (NGS) Market Drivers
Table 13. Next Generation Sequencing (NGS) Market Challenges
Table 14. Next Generation Sequencing (NGS) Market Restraints
Table 15. Global Next Generation Sequencing (NGS) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Next Generation Sequencing (NGS) Market Share by Players (2016-2021)
Table 17. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Sequencing (NGS) as of 2020)
Table 18. Ranking of Global Top Next Generation Sequencing (NGS) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Next Generation Sequencing (NGS) Product Solution and Service
Table 22. Date of Enter into Next Generation Sequencing (NGS) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2016-2021)
Table 26. Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Next Generation Sequencing (NGS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2016-2021)
Table 30. Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Illumina Company Details
Table 63. Illumina Business Overview
Table 64. Illumina Next Generation Sequencing (NGS) Product
Table 65. Illumina Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 66. Illumina Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Next Generation Sequencing (NGS) Product
Table 70. Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Pacific Biosciences of California Company Details
Table 73. Pacific Biosciences of California Business Overview
Table 74. Pacific Biosciences of California Next Generation Sequencing (NGS) Product
Table 75. Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 76. Pacific Biosciences of California Recent Development
Table 77. Beijing Genomics Institute Company Details
Table 78. Beijing Genomics Institute Business Overview
Table 79. Beijing Genomics Institute Next Generation Sequencing (NGS) Product
Table 80. Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 81. Beijing Genomics Institute Recent Development
Table 82. Qiagen Company Details
Table 83. Qiagen Business Overview
Table 84. Qiagen Next Generation Sequencing (NGS) Product
Table 85. Qiagen Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 86. Qiagen Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Next Generation Sequencing (NGS) Product
Table 90. Roche Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Agilent Technologies Company Details
Table 93. Agilent Technologies Business Overview
Table 94. Agilent Technologies Next Generation Sequencing (NGS) Product
Table 95. Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 96. Agilent Technologies Recent Development
Table 97. Perkinelmer Company Details
Table 98. Perkinelmer Business Overview
Table 99. Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 100. Perkinelmer Recent Development
Table 101. Genomatix Company Details
Table 102. Genomatix Business Overview
Table 103. Genomatix Next Generation Sequencing (NGS) Product
Table 104. Genomatix Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 105. Genomatix Recent Development
Table 106. PierianDx Company Details
Table 107. PierianDx Business Overview
Table 108. PierianDx Next Generation Sequencing (NGS) Product
Table 109. PierianDx Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 110. PierianDx Recent Development
Table 111. Eurofins Scientific Company Details
Table 112. Eurofins Scientific Business Overview
Table 113. Eurofins Scientific Next Generation Sequencing (NGS) Product
Table 114. Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 115. Eurofins Scientific Recent Development
Table 116. Gatc Biotech Company Details
Table 117. Gatc Biotech Business Overview
Table 118. Gatc Biotech Next Generation Sequencing (NGS) Product
Table 119. Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 120. Gatc Biotech Recent Development
Table 121. Oxford Nanopore Technologies Company Details
Table 122. Oxford Nanopore Technologies Business Overview
Table 123. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product
Table 124. Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 125. Oxford Nanopore Technologies Recent Development
Table 126. Bio-Rad Laboratories Company Details
Table 127. Bio-Rad Laboratories Business Overview
Table 128. Bio-Rad Laboratories Next Generation Sequencing (NGS) Product
Table 129. Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 130. Bio-Rad Laboratories Recent Development
Table 131. DNASTAR Company Details
Table 132. DNASTAR Business Overview
Table 133. DNASTAR Next Generation Sequencing (NGS) Product
Table 134. DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 135. DNASTAR Recent Development
Table 136. Biomatters Company Details
Table 137. Biomatters Business Overview
Table 138. Biomatters Next Generation Sequencing (NGS) Product
Table 139. Biomatters Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 140. Biomatters Recent Development
Table 141. Partek Company Details
Table 142. Partek Business Overview
Table 143. Partek Next Generation Sequencing (NGS) Product
Table 144. Partek Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 145. Partek Recent Development
Table 146. New England Biolabs Company Details
Table 147. New England Biolabs Business Overview
Table 148. New England Biolabs Next Generation Sequencing (NGS) Product
Table 149. New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 150. New England Biolabs Recent Development
Table 151. Myriad Genetics Company Details
Table 152. Myriad Genetics Business Overview
Table 153. Myriad Genetics Next Generation Sequencing (NGS) Product
Table 154. Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 155. Myriad Genetics Recent Development
Table 156. Macrogen Company Details
Table 157. Macrogen Business Overview
Table 158. Macrogen Next Generation Sequencing (NGS) Product
Table 159. Macrogen Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 160. Macrogen Recent Development
Table 161. GATC Biotech Company Details
Table 162. GATC Biotech Business Overview
Table 163. GATC Biotech Next Generation Sequencing (NGS) Product
Table 164. GATC Biotech Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 165. GATC Biotech Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Sequencing (NGS) Market Share by Type: 2020 VS 2027
Figure 2. Consumables Features
Figure 3. Platforms Features
Figure 4. Services Features
Figure 5. Global Next Generation Sequencing (NGS) Market Share by Application: 2020 VS 2027
Figure 6. Academic & Government Research Institutes Case Studies
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Biotechnology Companies Case Studies
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Next Generation Sequencing (NGS) Report Years Considered
Figure 11. Global Next Generation Sequencing (NGS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Next Generation Sequencing (NGS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Next Generation Sequencing (NGS) Market Share by Regions: 2020 VS 2027
Figure 14. Global Next Generation Sequencing (NGS) Market Share by Regions (2022-2027)
Figure 15. Global Next Generation Sequencing (NGS) Market Share by Players in 2020
Figure 16. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Sequencing (NGS) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Revenue in 2020
Figure 18. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2016-2021)
Figure 19. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2022-2027)
Figure 20. North America Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 22. North America Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 23. North America Next Generation Sequencing (NGS) Market Share by Country (2016-2027)
Figure 24. United States Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 28. Europe Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 29. Europe Next Generation Sequencing (NGS) Market Share by Country (2016-2027)
Figure 30. Germany Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Next Generation Sequencing (NGS) Market Share by Region (2016-2027)
Figure 40. China Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 48. Latin America Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 49. Latin America Next Generation Sequencing (NGS) Market Share by Country (2016-2027)
Figure 50. Mexico Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Next Generation Sequencing (NGS) Market Share by Country (2016-2027)
Figure 56. Turkey Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Illumina Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 61. Pacific Biosciences of California Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 62. Beijing Genomics Institute Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 63. Qiagen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 65. Agilent Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 66. Perkinelmer Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 67. Genomatix Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 68. PierianDx Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 69. Eurofins Scientific Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 70. Gatc Biotech Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 71. Oxford Nanopore Technologies Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 72. Bio-Rad Laboratories Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 73. DNASTAR Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 74. Biomatters Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 75. Partek Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 76. New England Biolabs Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 77. Myriad Genetics Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 78. Macrogen Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 79. GATC Biotech Revenue Growth Rate in Next Generation Sequencing (NGS) Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Global Next Generation Sequencing (NGS) Market Size, Status and Forecast 2021-2027
QYR2104Z4131 2021年4月 127Pages
QYResearch社発行の本調査資料では、次世代シーケンシング（NGS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、プラットフォーム、サービス）、用途別市場規模（学術＆政府研究機関、製薬会社、バイオテクノロジー会社、病院＆クリニッ...

世界の次世代シーケンシング（NGS）データ分析市場規模・現状・予測（2021年-2027年）

Global Next Generation Sequencing (NGS) Data Analysis Market Size, Status and Forecast 2021-2027
QYR2104Z4130 2021年4月 90Pages
QYResearch社発行の本調査資料では、次世代シーケンシング（NGS）データ分析のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成別シーケンシング（SBS）技術、単一分子リアルタイムシーケンシング（SMRT）技術、イオン半導体シーケンシン...

世界の臨床腫瘍学次世代シーケンシング（NGS）市場規模・現状・予測（2021年-2027年）

Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2021-2027
QYR2104Z1374 2021年4月 134Pages
QYResearch社発行の本調査資料では、臨床腫瘍学次世代シーケンシング（NGS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NGSプレシーケンシング、シーケンシング、NGSデータ分析、一次、二次、三次データ分析）、用途別市場規模（学術・...

世界の第3世代シーケンス市場規模・現状・予測（2021年-2027年）

Global Third-Generation Sequencing Market Size, Status and Forecast 2021-2027
QYR2104Z5633 2021年4月 95Pages
QYResearch社発行の本調査資料では、第3世代シーケンスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単一分子リアルタイム（SMRT）DNAシーケンス、ナノポアベース型単一分子分析技術、その他）、用途別市場規模（腫瘍学、遺伝性疾患検出、...

世界の次世代シーケンシング市場規模・現状・予測（2021年-2027年）

Global Next-Generation Sequencing Market Size, Status and Forecast 2021-2027
QYR2104Z4141 2021年4月 97Pages
QYResearch社発行の本調査資料では、次世代シーケンシングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ターゲットシーケンシング＆リシーケンシング、全ゲノムシーケンシング、全エクソームシーケンシング）、用途別市場規模（腫瘍、遺伝性疾患検...

世界の次世代シーケンシング情報市場規模・現状・予測（2021年-2027年）

Global Next-Generation Sequencing Informatics Market Size, Status and Forecast 2021-2027
QYR2104Z4140 2021年4月 92Pages
QYResearch社発行の本調査資料では、次世代シーケンシング情報のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NGS情報サービス、データ分析＆管理ツール、一次＆二次データ分析ツール）、用途別市場規模（病院・診療所、学術研究機関、製薬会社、...

世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年）

Global High-Throughput Sequencing (HTS) Market Size, Status and Forecast 2021-2027
QYR2104Z2845 2021年4月 93Pages
QYResearch社発行の本調査資料では、ハイスループットシーケンシング（HTS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成シーケンシング、連結シーケンシング）、用途別市場規模（腫瘍、遺伝性疾患検出、生命科学）、主要地域別市場規模（...

世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年）

世界の次世代車載ネットワーク（IVN）市場規模・現状・予測（2021年-2027年）

Global Next Generation In-Vehicle Networking (IVN) Market Size, Status and Forecast 2021-2027
QYR2104Z4127 2021年4月 134Pages
QYResearch社発行の本調査資料では、次世代車載ネットワーク（IVN）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（配線、リレー、スイッチ、センサーメモリ、その他）、用途別市場規模（インフォテインメント、気候制御、ナビゲーション、運転支...

世界の次世代インプラント（NGI）市場規模・現状・予測（2021年-2027年）

Global Next Generation Implants (NGI) Market Size, Status and Forecast 2021-2027
QYR2104Z4125 2021年4月 127Pages
QYResearch社発行の本調査資料では、次世代インプラント（NGI）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（金属＆金属合金、セラミック、ポリマー、生物製剤、その他）、用途別市場規模（整形外科インプラント、心臓血管インプラント、眼イン...

世界の次世代シーケンシング（NGS）市場規模・現状・予測（2021年-2027年） NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing. The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud compu…
世界の次世代シーケンシング（NGS）データ分析市場規模・現状・予測（2021年-2027年） North America is home to several well-established organizations of NGS data analysis. A significant number of NGS research projects are being carried out in Canadian universities, which in turn has resulted into huge demand for NGS data analysis, thereby affecting the revenue growth in the region. N…
世界の第3世代シーケンス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Third-Generation Sequencing Market The global Third-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
世界の次世代シーケンシング情報市場規模・現状・予測（2021年-2027年） Next-Generation Sequencing Informatics, also known as High-throughput sequencing, is marked by the ability to sequence one hundred thousand to one million DNA molecules in parallel, often with short readings. Market Analysis and Insights: Global Next-Generation Sequencing Informatics Market The glob…
世界の次世代シーケンシング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Next-Generation Sequencing Market The global Next-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …